JUN and neoplasm: For instance, increased expression of c-Jun, JNK, phosphorylated c-Jun, and phosphorylated JNK protein was associated with tumor (T), nodes (N), and metastases (M) staging and was expressed at significantly higher levels in patients with stage III–IV than those with I–II stage NPC [59].